The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Blood substitutes: why haven’t we been more successful?
Open accessAbstract
Persistent safety concerns have stalled the development of viable hemoglobin (Hb)-based oxygen carriers (HBOCs). HBOCs have several advantages over human blood, including availability, long-term storage and lack of infectious risk. The basis of HBOC toxicity is poorly understood, however several mechanisms have been suggested, including Hb extravasation across the blood vessel wall, scavenging of endothelial nitric oxide (NO), oversupply of oxygen, and heme-mediated oxidative side reactions. Although there are some in vitro and limited animal studies supporting these mechanisms, heme mediated reactivity appears to provide an alternative path that can explain some of the observed pathophysiological changes. Moreover, recent mechanistic and animal studies support a role for globin and heme scavengers in controlling oxidative toxicity associated with Hb infusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695 · cited 2×
“Free Hb toxicity in murine sickle cell mouse models was also inhibited by Hp or hemopexin or the combination of the two proteins [45].”
BackgroundSelf-citationMechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Characterization of Heme as Activator of Toll-like Receptor 4
Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., Oliveira, M. F., Oliveira, P. L., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610737200 · Cited by 576 · cited 1×
“Heme due to its hydrophobicity enters cell membrane for example, heme can activate the toll-like receptors (TLRs), particularly, TLR-4 which triggers a cascade of inflammatory responses [44].”
BackgroundThe Redox Activity of Hemoglobins: From Physiologic Functions to Pathologic Mechanisms
Reeder, B. J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2974 · Cited by 189
Hemoglobin-Mediated, Hypoxia-Induced Vasodilation via Nitric Oxide
Robinson, J. M., & Lancaster, J. R. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.f292 · Cited by 104
Cited by
Aggressive Man‐Made Red Blood Cells for Hypoxia‐Resistant Photodynamic Therapy
Liu, W., Liu, T., Zou, M., Yu, W., Li, C., He, Z., Zhang, M., Liu, M., Li, Z., Feng, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201802006 · Cited by 310
Indications for and Adverse Effects of Red-Cell Transfusion
Carson, J. L., Triulzi, D. J., & Ness, P. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1612789 · Cited by 253
Photosynthetic Microorganisms for the Oxygenation of Advanced 3D Bioprinted Tissues
Ortega, J. S., Corrales-Orovio, R., Ralph, P., Egaña, J. T., & Gentile, C. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.05.009 · Cited by 47
Metadata
- Authors
- Alayash, A. I.
- Venue
- Trends in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 32
- Issue
- 4
- Pages
- 177-185
- ISSN
- 0167-7799 (ISSN-L)
- OpenAlex
- W2047445353
- Cited by
- 179
- References
- 5
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood substitutes: why haven’t we been more successful? https://app.cochat.ai/papers/10.1016/j.tibtech.2014.02.006
- The paper
- Alayash, A. I. (2014). Blood substitutes: why haven’t we been more successful? Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2014.02.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.